clarithromycin has been researched along with Adenocarcinoma, Mucinous in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dubois, A; Francis, J; Jia, Y; Liu, H; McAvoy, TJ; Merrell, DS; Nieroda, C; Sardi, A; Semino-Mora, C; Studeman, K; Testerman, TL; Whitmire, JM | 1 |
1 trial(s) available for clarithromycin and Adenocarcinoma, Mucinous
Article | Year |
---|---|
Antibiotic treatment decreases microbial burden associated with pseudomyxoma peritonei and affects β-catenin distribution.
Topics: Adenocarcinoma, Mucinous; Amoxicillin; Anti-Bacterial Agents; Bacterial Load; beta Catenin; Cell Membrane; Cell Nucleus; Clarithromycin; Combined Modality Therapy; Helicobacter Infections; Helicobacter pylori; Humans; In Situ Hybridization; Lansoprazole; Middle Aged; Peritoneal Neoplasms; Protein Transport; Pseudomyxoma Peritonei; Treatment Outcome | 2013 |